Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Pollack

Showing results (231-240 of 265) with videos related to

Pageof 27
Sort By:
Urology|September 17, 2002
Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancerPeter R Carroll, Philip W Kantoff, Steven P Balk, et al.
Academic Radiology|December 18, 2024
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of ProgressionIsabella M Kimbel, Veronica Wallaengen, Evangelia I Zacharaki, et al.
BJU International|May 6, 2026
Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trialSeyed Hossein Hosseini Sharifi, Adam Williams, Jonathan T Ryan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 10, 2009
Bladder cancer. Clinical practice guidelines in oncologyJames E Montie, Robert R Bahnson, Samuel M Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Bladder cancer. Clinical guidelines in oncologyJames E Montie, Neil A Abrahams, Robert R Bahnson, et al.
European Urology|November 13, 2017
Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate CancerStephen J Ramey, Shree Agrawal, Matthew C Abramowitz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2016
Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational StudyThomas M Pisansky, Shree Agrawal, Daniel A Hamstra, et al.
Cancers|March 14, 2026
mpMRI-Based Risk Estimation to Optimize Prostate Cancer Patient Selection for Active SurveillanceVeronica Wallaengen, Evangelia I Zacharaki, Mohammad Alhusseini, et al.
European Urology Oncology|November 14, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 TrialsKrishnan R Patel, Paul L Nguyen, James A Proudfoot, et al.
BJU International|February 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)Ankur Malpani, Jonathan T Ryan, Hui Yu, et al.
Pageof 27

Showing results (231-240 of 265) with videos related to

Sort By:
Pageof 27
Urology|September 17, 2002
Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancerPeter R Carroll, Philip W Kantoff, Steven P Balk, et al.
Academic Radiology|December 18, 2024
HRS Improves Active Surveillance for Prostate Cancer by Timely Identification of ProgressionIsabella M Kimbel, Veronica Wallaengen, Evangelia I Zacharaki, et al.
BJU International|May 6, 2026
Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trialSeyed Hossein Hosseini Sharifi, Adam Williams, Jonathan T Ryan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 10, 2009
Bladder cancer. Clinical practice guidelines in oncologyJames E Montie, Robert R Bahnson, Samuel M Cohen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 23, 2006
Bladder cancer. Clinical guidelines in oncologyJames E Montie, Neil A Abrahams, Robert R Bahnson, et al.
European Urology|November 13, 2017
Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate CancerStephen J Ramey, Shree Agrawal, Matthew C Abramowitz, et al.
International Journal of Radiation Oncology, Biology, Physics|October 18, 2016
Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy-A Multi-Institutional Observational StudyThomas M Pisansky, Shree Agrawal, Daniel A Hamstra, et al.
Cancers|March 14, 2026
mpMRI-Based Risk Estimation to Optimize Prostate Cancer Patient Selection for Active SurveillanceVeronica Wallaengen, Evangelia I Zacharaki, Mohammad Alhusseini, et al.
European Urology Oncology|November 14, 2024
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 TrialsKrishnan R Patel, Paul L Nguyen, James A Proudfoot, et al.
BJU International|February 27, 2026
Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)Ankur Malpani, Jonathan T Ryan, Hui Yu, et al.
Pageof 27